The Neuro joins neuroscience data sharing partnership

Extra! Extra!

Today Health Canada and Brain Canada announced a $10M grant to establish the Canadian Open Neuroscience Platform, a partnership of researchers from 15 universities that will facilitate the dissemination of neuroscience data.

Canadian brain bank network to advance research on Alzheimer’s


To advance our understanding of dementia and contribute to the search for new treatments, the Government of Canada announced yesterday that it is investing $2.5 million in research. A pair of projects, led by McGill researchers Howard Chertkow and Nahum Sonenberg, will benefit from the funding.

A non-invasive method to detect Alzheimer’s disease


New research has drawn a link between changes in the brain’s anatomy and biomarkers that are known to appear at the earliest stages of Alzheimer’s disease (AD), findings that could one day provide a sensitive but non-invasive test for AD before cognitive symptoms appear.

Artificial intelligence predicts dementia before onset of symptoms


Imagine if doctors could determine, many years in advance, who is likely to develop dementia. Such prognostic capabilities would give patients and their families time to plan and manage treatment and care. Thanks to artificial intelligence research conducted at McGill, this kind of predictive power could soon be available to clinicians everywhere.

McGill researchers receive over $7M to fight brain diseases of aging


The Weston Brain Institute awards over $30 million nationally for high-risk, high-reward translational research projects to help speed up the development of treatments for neurodegenerative diseases of aging. The Institute will help fund the work of five McGill researchers.

“Big Data” study discovers earliest sign of Alzheimer’s


Scientists at the Montreal Neurological Institute and Hospital have used a powerful tool to better understand the progression of late-onset Alzheimer’s disease, identifying its first physiological signs. The research underlines importance of computational power in future neurological breakthroughs.

Alzheimer’s disease: It takes two (proteins) to tango


For years, neuroscientists have puzzled over how two abnormal proteins, called amyloid and tau, accumulate in the brain and damage it to cause Alzheimer’s disease. Which one is the driving force behind dementia? The answer: both of them, according to a new study.

Brain research gets $6-million boost


McGill-affiliated brain researchers have received a close to $6 million in funding, for innovative projects to accelerate diagnosis and drug discovery for diseases of the brain, including Alzheimer’s.